1. New Pharmacologic Approaches to the Treatment of Bipolar Depression

   • Kamyar Keramatian
   • Trisha Chakrabarty
   • Lakshmi N. Yatham

   Leading Article 25 May 2023 Pages: 843 - 863

2. Intravenous Methadone for Perioperative and Chronic Cancer Pain: A Review of the Literature

   • Sebastiano Mercadante

   Review Article 13 June 2023 Pages: 865 - 871

3. Targeting IL-23 for IBD: Rationale and Progress to Date

   • Sudheer K. Vuyyuru
   • Lisa M. Shackelton
   • Brian G. Feagan

   Review Article 02 June 2023 Pages: 873 - 891

   

4. Acute Graft-versus-Host Disease: An Update on New Treatment Options

   • Dilan A. Patel
   • Mallory Crain
   • Mark A. Schroeder

   Review Article 29 May 2023 Pages: 893 - 907

5. The Effect of Biological Treatment on Fatigue in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis

   • Berit Mære Skjellerudsveen
   • Inger Marie Skoie
   • Roald Omdal

   Systematic Review Open access 23 May 2023 Pages: 909 - 921

   

6. Fenfluramine: A Review in Dravet and Lennox-Gastaut Syndromes

   • James E. Frampton

   Adis Drug Evaluation Open access 15 June 2023 Pages: 923 - 934

7. Glofitamab: First Approval

   • Matt Shirley

   AdisInsight Report 07 June 2023 Pages: 935 - 941

   

8. Leniolisib: First Approval

   • Sean Duggan
   • Zaina T. Al-Salama

   AdisInsight Report 31 May 2023 Pages: 943 - 948

   

9. Correction to: Pegcetacoplan: A Review in Paroxysmal Nocturnal Haemoglobinuria

   • Young-A. Heo

   Correction Open access 01 June 2023 Pages: 949 - 949

10. Correction to: Nadofaragene Firadenovec: First Approval

    • Arnold Lee

    Correction Open access 03 June 2023 Pages: 951 - 951

11. Correction to: Efanesoctocog Alfa: First Approval

    • Susan J. Keam

    Correction Open access 03 June 2023 Pages: 953 - 953

12. Correction to: Sparsentan: First Approval

    • Yahiya Y. Syed

    Correction Open access 06 June 2023 Pages: 955 - 955